Andrew Robbins is Chief Executive Officer, President and Director of Cogent Biosciences, Inc. (COGT). The company reported total compensation of $27,762,684 for fiscal year 2025.
| Salary | $724,554 |
|---|---|
| Bonus | $21,600 |
| Stock awards | $12,993,250 |
| Option awards | $13,447,680 |
| Non-equity incentive plan | $561,600 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $14,000 |
| Total | $27,762,684 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Cogent Biosciences, Inc. filed April 23, 2026, accession 0001193125-26-173834.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chief Executive Officer, President and Director | $724,554 | $21,600 | $12,993,250 | $13,447,680 | $561,600 | $0 | $14,000 | $27,762,684 |
| FY2024 | Chief Executive Officer | $692,000 | $0 | $0 | $3,734,610 | $477,480 | $0 | $13,800 | $4,917,890 |
| FY2023 | Chief Executive Officer | $656,098 | $393,659 | $1,873,200 | $4,962,615 | $13,200 | $0 | $0 | $7,898,772 |
Totals as disclosed in each year's own compensation disclosure for Cogent Biosciences, Inc..
| Peer-group chief executive median | $6,238,783 |
|---|---|
| Difference from that median | $21,523,901 |
| Percentile within the disclosed peer group | 99th |
| Peers with a disclosed figure | 19 |
Medians and percentiles are computed across the peer group Cogent Biosciences, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Andrew Robbins this page | Chief Executive Officer, President and Director | $27,762,684 |
| Jessica Sachs | Chief Medical Officer | $9,178,177 |
| John Robinson | Chief Scientific Officer | $9,150,297 |
| Cole Pinnow | Chief Commercial Officer | $8,839,548 |
| John Green | Chief Financial Officer | $8,546,329 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Cogent Biosciences, Inc. compensation brief.
Andrew Robbins's compensation sits inside Cogent Biosciences, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.